Ola Olén

Ola Olén

Adjunct Professor
Visiting address: Maria Aspmans gata 30A, 17164 Solna
Postal address: K2 Medicin, Solna, K2 KEP Olén O, 171 77 Stockholm

About me

  • Ola Olén is Adjunct Professor of Gastroenterology at the Division of Clinical Epidemiology at the Department of Medicine Solna, Karolinska Institutet. He is also a senior consultant at the Department of pediatric gastroenterology and nutrition at Sachs’ children and youth hospital, Stockholm.

Research

  • The aim of my research is to improve health care and ultimately quality of life for patients suffering from diseases such as inflammatory bowel disease (IBD) or disorders of gut brain interaction such as irritable bowel syndrome (IBS).

    IBD

    As a pediatric gastroenterologist, most of my clinical time is devoted to patients with IBD. They are sometimes severely ill and require advanced treatment. In my research group, we use large register-based linkages including all IBD patients in Sweden and matched controls. Our IBD research is conducted in national and international collaboration and is based on clinical data in national health registers and local registers or biobanks. Important research questions that we explore are for instance: Why do some people get IBD? What is the prognosis for different patient groups with IBD (and especially for patients with childhood onset)? Are new treatments for IBD effective? Are they safe? And are they cost effective?

    IBS

    Irritable bowel syndrome (IBS) and other types of functional abdominal pain disorders are very common: Approximately 3% of all visits to the general practitioner, 10% of visits to general pediatricians and 20% of visits to a pediatric gastroenterology unit. It is well known that cognitive behavior therapy and hypnotherapy are effective for children and adolescents with IBS, but access to trained therapists is very limited. In randomized clinical trials we test if it is possible to treat children and adolescents with IBS or functional abdominal pain via internet, thereby increasing accessibility to evidence-based treatments for these large patient groups. I am also trying to understand why so many children suffer from IBS by studying risk factors for disease in birth cohorts and national health registers. In these data sources we are studying the effects of genetics, perinatal risk factors, lifestyle, co-morbidity, gut flora, and use of antibiotics.

    I am a member of the steering committee for the national quality register for IBD care (www.swibreg.se), the steering group for the Swedish national guidelines in pediatric IBD, and of the Pediatric IBD Porto group of ESPGHAN (European Society for Paediatric Gastroenterology, Hepatology, and Nutrition). He is also a member of the steering groups for the Swedish national guidelines for pediatric functional abdominal pain disorders and pediatric celiac disease.

Teaching

  • Dr Olén is a valued teacher, regularly and often engaged as a lecturer regarding inflammatory bowel disease, irritable bowel syndrome, and epidemiology. Apart from his regular lectures, seminars, and bedside education of medical students at Karolinska Institutet, dr Olén has served as the director of studies 2009-2013 for the widely acclaimed Research school in epidemiology for clinicians at the Karolinska Instituet (Department of Medicine Solna) and 2014-2015 he was the director of studies for the Clinical research school (Department of Clinical Science and Education). He has been director of the national course in pediatric gastroenterology, hepatology, and nutrition, funded by the National Board of Health and Welfare 2012-2017.

    Former PhD students: Bonnert M, Uusijärvi A, Lalouni M, Granlund J, Schollin-Ask L, Forss A, Mouratidou N, Mahmood M, Thulin H, Jossan N.

    Current PhD students: Sjölund J, Andersson F

    Former Postodocs: Arnell H, Malmborg P, Everhov ÅH

    Current Postdocs: Bröms G, Eriksson C, Rolandsdotter H, Forss A, Soini T

Articles

All other publications

Grants

  • Inflammatory bowel disease and risk of cancer – a moving target in an age of new treatments and surveillance strategies
    ALF
    1 January 2023 - 31 December 2024
  • Swedish Research Council
    1 January 2021 - 31 December 2026
    What (purpose and aim)To quantify how risk of and mortality from major malignancies in IBD (e.g., colorectal cancer [CRC], small bowel cancer, lymphoma, liver cancer, pancreatic cancer, and skin cancer) in patients with inflammatory bowel disease (IBD) compared with the general populations of Sweden and Denmark has changed over the last 50 years. We also aim to disentangle the role of disease severity, disease duration, and treatment exposures (e.g. thiopurines and anti-TNF) in cancer development in IBD.HowRegister-based cohort studies: a Swedish-Danish collaboration where we have combined national healthcare registers with new databases, built by us, including detailed information about disease severity and degree of inflammation in the blood and gut. We have created the hitherto largest high-resolution database that for the first time makes it possible to study clinically crucial issues while handling shortcomings of earlier research. Why (Significance)Ultimately, this project has the potential to lead to a currently missing reliable risk prediction tool regarding relevant malignancies in different IBD sub-groups and will contribute significantly to development of updated evidence-based guidelines regarding treatment and cancer surveillance tailored to the individual IBD-patient.
  • Inflammatory bowel disease and cancer risk - a moving target in an era of new immunomodulatory therapies
    Swedish Research Council
    1 January 2021 - 31 December 2024
  • Scandinavian CANcer-in-Inflammatory Bowel Disease study (SCAN-IBD)
    FORTE
    1 January 2018 - 31 December 2019
  • Swedish Research Council for Health Working Life and Welfare
    1 January 2017 - 31 December 2019
  • Improved access and delivery of treatment to children and adolescents through Internet-based cognitive behavior therapy: From development to implementation in regular health care
    Swedish Research Council for Health, Working life and Welfare
    1 January 2015 - 31 December 2020
  • Internet-delivered cognitive behaviour therapy for children and adoelscents with functional abdominal pain disorders
    ALF
    1 January 2014 - 31 December 2016
  • Internet-delivered cognitive behaviour therapy for adolescents with functional gastrointestinal disorders
    Jane and Dan Olsson foundation
    1 June 2013 - 31 December 2015
  • Internet-delivered cognitive behaviour therapy for adolescents with functional gastrointestinal disorders
    Kempe Carlgrenska Foundation
    1 January 2012 - 31 December 2017

Employments

  • Senior consultant in paediatrics, Sachs' Children and Youth Hospital, 2016-
  • Adjunct Professor, Department of Medicine, Karolinska Institutet, 2024-2028
  • Adjunct Senior Lecturer, Department of Medicine, Karolinska Institutet, 2023-2024

Degrees and Education

  • Docent, Karolinska Institutet, 2020
  • Degree Of Doctor Of Philosophy, Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, 2008

News from KI

Events from KI